| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8535508 | Life Sciences | 2018 | 6 Pages |
Abstract
Our data suggest that S1P protects in an ex-vivo rat heart model of AHF by activation of STAT3 and provide further evidence for the usage of S1P as a potential therapy in patients suffering from AHF.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Gaurang P. Deshpande, Aqeela Imamdin, Sandrine Lecour, Lionel H. Opie,